Gut

Immune-related adverse events are a potent predictor of post-transplant rejection in HCC: a multicentre retrospective cohort study

Background Immune checkpoint inhibitors (ICIs) enable successful hepatocellular carcinoma (HCC) downstaging or bridging for ...